title: Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.
abstract: An adequate balance between serine proteases and their plasminogen activator inhibitor-1 (PAI-1) is critical for pathological angiogenesis. PAI-1 deficiency in mice is associated with impaired choroidal neovascularization (CNV) and tumoral angiogenesis. In the present work, we demonstrate unexpected differences in the contribution of bone marrow (BM)-derived cells in these two processes regulated by PAI-1. PAI-1(-/-) mice grafted with BM-derived from wild-type mice were able to support laser-induced CNV formation but not skin carcinoma vascularization. Engraftment of irradiated wild-type mice with PAI-1(-/-) BM prevented CNV formation, demonstrating the crucial role of PAI-1 delivered by BM-derived cells. In contrast, the transient infiltration of tumor transplants by local PAI-1-producing host cells rather than by BM cells was sufficient to rescue tumor growth and angiogenesis in PAI-1-deficient mice. These data identify PAI-1 as a molecular determinant of a local permissive soil for tumor angiogenesis. Altogether, the present study demonstrates that different cellular mechanisms contribute to PAI-1-regulated tumoral and CNV. PAI-1 contributes to BM-dependent choroidal vascularization and to BM-independent tumor growth and angiogenesis.
authors: Laboratory of Tumor and Developmental Biology, University of Liège, Tour de Pathologie, CHU (B23), Sart Tilman; B-4000 Liège, Belgium.
authors: Maud
authors: M
authors: Jost
authors: Catherine
authors: C
authors: Maillard
authors: Julie
authors: J
authors: Lecomte
authors: Vincent
authors: V
authors: Lambert
authors: Marc
authors: M
authors: Tjwa
authors: Pierre
authors: P
authors: Blaise
authors: Maria-Luz
authors: ML
authors: Alvarez Gonzalez
authors: Khalid
authors: K
authors: Bajou
authors: Silvia
authors: S
authors: Blacher
authors: Patrick
authors: P
authors: Motte
authors: Chantal
authors: C
authors: Humblet
authors: Marie Paule
authors: MP
authors: Defresne
authors: Marc
authors: M
authors: Thiry
authors: Francis
authors: F
authors: Frankenne
authors: André
authors: A
authors: Gothot
authors: Peter
authors: P
authors: Carmeliet
authors: Jean-Marie
authors: JM
authors: Rakic
authors: Jean-Michel
authors: JM
authors: Foidart
authors: Agnès
authors: A
authors: Noël
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000502:physiology*; D016026:Bone Marrow Transplantation; D002277:Carcinoma / Q000098:blood supply*; D020256:Choroidal Neovascularization / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D015603:Keratinocytes / Q000473:pathology / Q000637:transplantation; D051379:Mice; D008822:Mice, Transgenic; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics / Q000502:physiology*; D012878:Skin Neoplasms / Q000098:blood supply*
chemical_list: D017395:Plasminogen Activator Inhibitor 1
references: Brain Pathol. 2003 Oct;13(4):582-97
references: 14655762
references: J Cell Biol. 1996 Sep;134(6):1563-71
references: 8830783
references: Nat Med. 1998 Aug;4(8):923-8
references: 9701244
references: J Clin Oncol. 2005 Feb 10;23(5):1011-27
references: 15585754
references: FASEB J. 2002 Feb;16(2):267-9
references: 11772950
references: J Clin Pathol. 2004 Jun;57(6):577-84
references: 15166260
references: Nat Med. 2005 Feb;11(2):206-13
references: 15665831
references: Trends Cardiovasc Med. 2002 Feb;12(2):88-96
references: 11852257
references: Thromb Haemost. 2006 Apr;95(4):678-88
references: 16601839
references: Biochim Biophys Acta. 2006 Aug;1766(1):159-66
references: 16857321
references: Cancer Res. 2000 Oct 15;60(20):5839-47
references: 11059781
references: Cancer Res. 1994 Sep 1;54(17):4671-5
references: 8062262
references: Neoplasia. 2005 Jan;7(1):57-66
references: 15720817
references: FASEB J. 2002 Feb;16(2):147-54
references: 11818362
references: J Cell Biol. 2003 Mar 3;160(5):781-91
references: 12615913
references: Nat Rev Cancer. 2004 Nov;4(11):839-49
references: 15516957
references: Nature. 2004 Sep 23;431(7007):405-6
references: 15385993
references: Nat Med. 2005 Mar;11(3):261-2
references: 15723071
references: Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1050-5
references: 9448283
references: Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2791-7
references: 12766088
references: Semin Thromb Hemost. 1996;22(6):525-42
references: 9122719
references: Exp Eye Res. 2004 Jun;78(6):1107-16
references: 15109917
references: Exp Eye Res. 1996 Sep;63(3):233-44
references: 8943696
references: Oncogene. 2004 Sep 9;23(41):6986-90
references: 15286708
references: Cell. 2000 Oct 27;103(3):481-90
references: 11081634
references: Blood. 2004 Sep 15;104(6):1769-77
references: 15187022
references: Cancer Metastasis Rev. 1989 Aug;8(2):98-101
references: 2673568
references: J Cell Biol. 2001 Feb 19;152(4):777-84
references: 11266468
references: Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3186-93
references: 12824270
references: Blood. 2004 Oct 1;104(7):2084-6
references: 15191949
references: Nat Med. 2001 Nov;7(11):1194-201
references: 11689883
references: Circ Res. 2004 Feb 6;94(2):230-8
references: 14656934
references: Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4908-13
references: 14578416
references: Circ Res. 1999 Aug 6;85(3):221-8
references: 10436164
references: FASEB J. 2005 Feb;19(2):234-6
references: 15550552
references: Am J Ophthalmol. 1999 Apr;127(4):477-8
references: 10218712
references: FASEB J. 2001 Apr;15(6):1021-7
references: 11292663
references: Differentiation. 2002 Dec;70(9-10):486-97
references: 12492491
references: Nat Rev Cancer. 2002 Nov;2(11):826-35
references: 12415253
references: Mol Ther. 2005 Dec;12(6):994-1005
references: 16137927
references: Stem Cells. 2004;22(1):21-6
references: 14688388
references: Nat Med. 2003 Jun;9(6):653-60
references: 12778163